Wayne Weisman Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Wayne Weisman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Wayne Weisman. Wayne Weisman is Director in Recro Pharma, Inc. ($REPH) and in ReWalk Robotics Ltd. ($RWLK) and Director in ReWalk Robotics Ltd. ($RWLK) and Director in Baudax Bio, Inc. ($BXRX).
Wayne Weisman in Recro Pharma, Inc.
Trading Symbol: REPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Wayne Weisman: Director
Holdings: 84,982 shares
Current Value: $684,105
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Wayne Weisman in Recro Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXRX, REPH, RWLK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
Apr 22 2021 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 26,923 | 0 | 84,982 | 58.1 K to 85 K (+46.37 %) |
May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 8,363 | 0 | 58,059 | 49.7 K to 58.1 K (+16.83 %) |
Dec 09 2019 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 15,284 | 0 | 49,696 | 34.4 K to 49.7 K (+44.41 %) |
May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | M | 0.00 | 13,274 | 0 | 26,457 | 13.2 K to 26.5 K (+100.69 %) |
May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 6,183 | 0 | 13,183 | 7 K to 13.2 K (+88.33 %) |
May 16 2017 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
Dec 19 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | P | 6.57 | 3,000 | 19,710 | 7,000 | 4 K to 7 K (+75.00 %) |
Dec 19 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | P | 6.53 | 4,000 | 26,120 | 4,000 | 0 to 4 K |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.45 | 5,008 | 32,326 | 778,634 | 783.6 K to 778.6 K (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.45 | 14,992 | 96,770 | 2,330,321 | 2.3 M to 2.3 M (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.46 | 1,252 | 8,083 | 783,642 | 784.9 K to 783.6 K (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.46 | 3,748 | 24,197 | 2,345,313 | 2.3 M to 2.3 M (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 150 | 1,350 | 784,894 | 785 K to 784.9 K (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 450 | 4,050 | 2,349,061 | 2.3 M to 2.3 M (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 2,250 | 20,252 | 785,044 | 787.3 K to 785 K (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 6,737 | 60,639 | 2,349,511 | 2.4 M to 2.3 M (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 1,553 | 13,977 | 787,294 | 788.8 K to 787.3 K (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 4,648 | 41,832 | 2,356,248 | 2.4 M to 2.4 M (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.01 | 691 | 6,223 | 788,847 | 789.5 K to 788.8 K (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.01 | 2,068 | 18,624 | 2,360,896 | 2.4 M to 2.4 M (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 3,702 | 33,321 | 789,538 | 793.2 K to 789.5 K (-0.47 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 11,082 | 99,748 | 2,362,964 | 2.4 M to 2.4 M (-0.47 %) |
Dec 18 2015 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | C | 5.00 | 1,875,000 | 9,375,000 | 0 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.00 | 20,000 | 160,000 | 20,000 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | C | 0.00 | 2,045,738 | 0 | 3,167,286 | 1.1 M to 3.2 M (+182.40 %) |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | C | 0.00 | 1,121,548 | 0 | 1,121,548 | 0 to 1.1 M |
Page: 1